| Name | 3'-deoxy-3'-iodothymidine |
|---|---|
| Synonyms |
3'-Iodo-3'-deoxy-D-thymidine
3’-Deoxy-3’-iodothymidine THYMIDINE,3'-DEOXY-3'-IODO 3'-DEOXY-3'-IODOTHYMIDINE 3’-Deoxy-3’-iodo thymidine, IddT, 2’,3’-Dideoxy-3’-iodo-5-methyluridine 3’-Deoxy-3’-iodothymidine, IddT, 3’-Deoxy-3’-iodo-5-methyluridine 3'-Deoxy-3'-iodothymidin THYMIDINE, 3'-DEOXY-3'-IODO 3'-IODOTHYMIDINE 3'-iodo-3'-deoxythymidine 1-(3-iodo-2,3-dideoxy-β-D-erythro-pentofuranosyl)thymine |
| Description | 3′-Deoxy-3′-iodothymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.91g/cm3 |
|---|---|
| Molecular Formula | C10H13IN2O4 |
| Molecular Weight | 352.13 |
| Exact Mass | 351.99200 |
| PSA | 84.32000 |
| Index of Refraction | 1.66 |
|
~%
14260-82-3 |
| Literature: Journal of Medicinal Chemistry, , vol. 53, # 10 p. 4130 - 4140 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |